A multicenter, double-blind, randomized study to compare the efficacy and safety of the combination of 145mg fenofibrate and simvastatin with 40mg simvastatin monotherapy in patients with mixed dyslipidemia at risk of cardiovascular disease not adequately controlled by 40 mg simvastatin alone

This clinical trial is studying A multicenter, double-blind, randomized study to compare the efficacy and safety of the combination of 145mg fenofibrate and simvastatin with 40mg simvastatin monotherapy in patients with mixed dyslipidemia at risk of cardiovascular disease not adequately controlled by 40 mg simvastatin alone. You may be eligible if you are people with mixed dyslipidemia with chd or chd risk equivalent or with multiple risk factor and a 10 year risk above or equal to 10% and with tg above 1. Participation typically involves medical assessments, possible treatment with the study intervention, and follow-up visits to track your health.